Type 1 diabetes.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing disease mechanisms, epidemiology, and management without primary data or systematic meta-analysis.
PubMed 29916386 · doi:10.1016/S0140-6736(18)31320-5
What was done
The authors synthesized literature on type 1 diabetes for a clinical Seminar, summarizing progress over the past 25 years regarding genetics, epidemiology, immune and beta-cell phenotypes, beta-cell preservation interventions, and clinical disease management.
What was found
The abstract reports no numerical results or statistical findings. It notes that while understanding of disease pathogenesis and management options has expanded, wide gaps remain in standardizing clinical care and reducing disease-associated complications and burden.
Why it matters
This seminar provides a consolidated high-level overview of current concepts in type 1 diabetes pathogenesis and management while highlighting priorities for future clinical research.
Limits
This is a narrative review rather than a systematic review or meta-analysis. The abstract provides no primary data, sample sizes, search strategy, or formal quality appraisal of cited evidence.
Cited by
- supports Type 1 diabetes is an autoimmune condition caused by the immune system attacking and destroying the pancreas.